AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01012661 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Radiesse® Injectable Dermal Filler Mixed with Lidocaine
Description: Calcium hydroxylapatite particles suspended in an aqueous based gel carrier mixed with 2% lidocaine hydrochloride (HCl)
Study NCT01012661 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Radiesse® Injectable Dermal Filler without Lidocaine
Description: Calcium hydroxylapatite particles suspended in an aqueous based gel carrier without 2% lidocaine hydrochloride (HCl)
Study NCT00603005 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Use of TravAlert dosing aid with or without drop guider
Description: Each patient will use a dosing aid and/or drop guider for 6 months
Study NCT04701125 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: selective head-neck cooling using PolarCap system
Description: Players receiving selective head-neck cooling after SRC
Study NCT01898663 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Adenovirus-transfected DC + CIK
Description: Adenovirus-transfected autologous DC vaccine plus CIK cells
Study NCT01128712 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Pregabalin
Description: 150 mg /day
Study NCT01128712 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Pregabalin
Description: 450 mg/day
Study NCT01065935 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ALN-RSV01
Description: Administered by nebulization once daily for 5 days
Study NCT01065935 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal Saline
Description: Administered by nebulization once daily for 5 days
Study NCT01477905 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Remi50 with prime
Description: for using experimental TCIs, targeting an effect-site concentration (Ceff) of 4.0 ng/ml, was performed using 50 μg/ml (Remi50) of remifentanil, with PRIMING
Study NCT01477905 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Remi20 with prime
Description: For using experimental TCIs, targeting an effect-site concentration (Ceff) of 4.0 ng/ml, was 20 μg/ml (Remi20) of remifentanil, and with PRIMING
Study NCT03797560 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ba-Duan-Jin
Description: Ba-Duan-Jin is a common form of self-health-care Qigong exercise that has been practiced by Chinese people for at least eight hundred years. It consists of eight sets of simple movements. By combining meditation with slow, graceful movements, deep breathing, and relaxation, Ba-Duan-Jin practitioners believe it has the ability to move vital energy (Qi) throughout the body. Ba-Duan-Jin is also considered to be a multicomponent intervention that integrates physical, psychosocial, emotional, spiritual, and behavioral elements. While the biological mechanisms remain unclear, previous clinical trials have demonstrated that Ba-Duan-Jin can improve sleep quality, physical health, and mental health in patients with various chronic diseases
Study NCT03797560 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pregabalin capsule
Description: Pregabalin is one of the three medications (pregabalin, duloxetine, and milnacipran) that have been approved by the Food and Drug Administration (FDA) to treat fibromyalgia in US, and the only medicine that has been approved in China.
Study NCT02655146 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: E2
Description: Patients will be on the Progynova tablets 4-10mg daily at least 14 days.
Study NCT02655146 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Progesterone
Description: After ultrasound and hormorne tests, progesterone 100mg intramuscular injection is allocated with Progynova.
Study NCT02655146 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Progesterone
Description: After ultrasound and hormorne tests, progesterone 100mg intramuscular injection is allocated with Progynova.
Study NCT02655146 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: triptorelin 3.75mg
Description: as a pretreatment of E2 in some subjects with a fail history of hormonal artificially endometrium preparing.
Study NCT02655146 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: triptorelin 3.75mg
Description: as a pretreatment of E2 in some subjects with a fail history of hormonal artificially endometrium preparing.
Study NCT00746408 — intervention group
Intervention type: OTHER
Intervention: Expert system guided tailored information
Description: The prototype is realised by a web-based information system. The HTML web-interface guides the user through the search process by querying the information demand. This is done by an integrated expert system. The expert system uses a rule based inference to determine an internal diagnosis. Based on this internal diagnosis the system searches quality labeled websites and presents relevant information to the user.
Study NCT00101829 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: 1000 mg intravenous infusion
Study NCT02688374 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Treatment C: Nicotinell 2 mg coated fruit flavor gum
Description: Participants will be administered with 2 mg coated fruit flavor gum of Nicotinell
Study NCT03857581 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clozapine
Description: Subjects will be randomly assigned to clozapine or olanzapine and followed for up to 12 weeks with weekly visits.
Study NCT02632838 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iHealth BP7-Wireless Blood Pressure Wrist Monitor,
Description: The mHealth group will ask to use iHealth BP7-Wireless Blood Pressure Wrist Monitor at home. This monitor is a fully automatic wrist cuff blood pressure monitor that uses the oscillometric principle to measure blood pressure and pulse rate. The monitor works with mobile devices to test, track and share vital blood pressure data. The Bluetooth sync system allows the monitor to send BP measures and pulse rate to patients' mobile devices. The free iHealth app automatically keeps a history of BP data and gives patient the option to share their blood pressure data with their provider. In addition to keep the data on the mobile device, patient also receive a free and secure cloud account. Vital data on the cloud allows patients to access from any computer and to share with their provider.
Study NCT02251522 — intervention group
Intervention type: DEVICE
Intervention: ConforMIS Total Knee Replacement System
Description: Total knee replacement system using a patient specific implant.
Study NCT02251522 — intervention group
Intervention type: DEVICE
Intervention: Off-the-Shelf Knee Replacement System
Description: Total knee replacement system not using a patient specific implant.
Study NCT03716570 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIIB054
Description: Administered as specified in the treatment arm.
Study NCT03716570 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered as specified in the treatment arm.
Study NCT02981355 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Microfracture treatment
Description: Microfracture is performed by penetrating the subchondral bone beneath the cartilage lesion inducing a bleeding response.
Study NCT02981355 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Microfracture treatment
Description: Microfracture is performed by penetrating the subchondral bone beneath the cartilage lesion inducing a bleeding response.
Study NCT02981355 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BST-CarGel
Description: BST-CarGel is combined with fresh, autologous whole blood and applied to the lesion on the femoral condyle with a syringe following microfracture arthroscopic surgery.
Study NCT01701518 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Ozurdex
Description: biodegradable 0.7mg dexamethasone implant
Study NCT00943943 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF
Description: 10 microgram/kg subcutaneous injection based on adjusted ideal body weight and administered in the evening (prior to the Plerixafor). The 1st dose on day -1 and every other day for 7 total doses. G-CSF administration of 7 every-other-day doses will be repeated every 28 days.
Study NCT00943943 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Plerixafor
Description: A fixed dose of 240 mcg/kg subcutaneous injection in the abdomen, calculated on ideal body weight. The 1st dose on day -1 and every other day for 7 total doses. Plerixafor administration of 7 every-other-day doses will be repeated every 28 days.
Study NCT00943943 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sorafenib
Description: First dose will be given right after G-CSF and plerixafor injections. Drug doses will be separated by intervals of approximately 12 hours (+/-2 hours).~Dose Level 0 = 400 mg orally twice daily.
Study NCT01574742 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minocycline
Description: Minocycline 200 mg/day (2X100 mg) from day 1 to day 3 and Minocycline 400 mg/day (2X200mg) form day 4 until termination visit (day 35)
Study NCT04652739 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lycopene Softgel, 10 Mg
Description: Patients were given 10 mg of lycopene softgel capsules once daily for two months. The active ingredient in each capsule consists of 10 mg lycopene from natural tomato extract.
Study NCT04652739 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisolone
Description: Patients were given 40 mg of prednisolone tablets once daily in the morning for one month, afterwards, the dose was tapered along the following month. Incremental reduction of 10 mg each week for the first three weeks, followed by 5 mg reduction in the last week, was the tapering protocol in this study. The active ingredient in each tablet consists of Prednisolone metasulfobenzoate sodium 31.44 mg (equivalent to 20 mg of Prednisolone).
Study NCT02982278 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community-based Intervention under Nurse Guidance after Stroke
Description: CINGS is a 12-week nurse coordinated, Community Health Worker intervention structure. Intervention home visits will be conducted by the CHW and will include home-based training in self-care and self-management strategies alongside strategies to address risk of negative stroke outcomes that will be determined once these risk factors are identified and community-engaged approaches to their resolution derived. CHW efforts will be guided via televideo interactions with nurse coordinator. During home-visits, self-reported assessments will be collected via RedCap as well as assessments collected by the CHW and research nurse (weight, blood pressure, medication adherence). After baseline, participants randomized to the intervention group will have home visits, once a week for the first month, and biweekly for the other two months, conducted by the CHW. Additionally, there will be post-intervention follow-up assessments at 3, 6, and 12-month time intervals.
Study NCT01449695 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Life style counseling
Description: A nurse-based intervention with face-to-face contacts based on motivational interviewing techniques and influence on behavioral determinants. Well-trained nurses in our hospital will apply these behavioral change interventions. An individual contact will take about twenty minutes.
Study NCT01449695 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: an individualized web portal
Description: This website shows patient's lab results, life style issues, blood pressure and weight in various risk monitors. These lab results and lifestyle changes will be visualized in risk monitors and provide structural feedback to the patient. The results of the screening and the two additional visits can be seen by the patient.
Study NCT01449695 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: individual and group consultations
Description: group consultations with peers and a nurse individual consultation with a nurse
Study NCT01804985 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imatinib
Description: Imatinib, nilotinib or dasatinib; de-escalated to half the standard dose for 12 months. If on imatinib, the dose should be decreased to 200mg daily;
Study NCT01804985 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nilotinib
Description: Imatinib, nilotinib or dasatinib; de-escalated to half the standard dose for 12 months. if on nilotinib to 200mg twice daily (which is half the standard dose for second line use, since it is anticipated that the vast majority of nilotinib entrants will be receiving 400mg twice daily because of prior imatinib intolerance);
Study NCT01804985 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dasatinib
Description: Imatinib, nilotinib or dasatinib; de-escalated to half the standard dose for 12 months. If on dasatinib then to 50 mg daily.
Study NCT03065374 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IMM-529
Description: IMM-529
Study NCT03065374 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo
Study NCT04438239 — intervention group
Intervention type: OTHER
Intervention: none, this study is observational
Description: none, this study is observational
Study NCT03756259 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Mobile Health (mHealth) for Pneumonia
Description: Audiovisual mobile based application will be used to counsel caregivers of children under five on pneumonia and its prevention. This will be coupled with text and voice message dissemination to the cell phones of caregivers and active pneumonia case finding by the LHWs which will be managed according to severity.
Study NCT00064974 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CC-5013
Description: CC-5013 10 mg (two 5 mg capsules) daily on days 1-28 every 28 days (28 day cycles)
Study NCT02738086 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Activity Behavior Change (PABC)
Description: Home-based weekly sessions (30 min) using behavior change methods for promoting physical activity. Sessions will occur using home-based computer tablets for real-time video interface between the participant and therapist. Participants will wear wrist-mounted activity sensors with direct physical activity feedback during the intervention period to allow for behavioral feedback and action planning.
Study NCT02738086 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Activity Behavior Change (PABC)
Description: Home-based weekly sessions (30 min) using behavior change methods for promoting physical activity. Sessions will occur using home-based computer tablets for real-time video interface between the participant and therapist. Participants will wear wrist-mounted activity sensors with direct physical activity feedback during the intervention period to allow for behavioral feedback and action planning
Study NCT03559491 — intervention group
Intervention type: DRUG
Intervention: Intravitreal injection
Description: Long term release steroid injection
Study NCT03859102 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Pre-operative Carbohydrate PreLoad drink
Description: Pre-operative Carbohydrate PreLoad drink, 1 sachet given the night before surgery. One sachet given 2-4hours before surgery.
Study NCT03859102 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Gabapentin pre-op
Description: One dose of Gabapentin pre-operatively, 300mg orally.
Study NCT03859102 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Lansoprazole pre-op
Description: One dose of Lansoprazole pre-operatively, 30mg orally.
Study NCT03859102 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous Paracetamol intra-operatively
Description: One dose of Paracetamol intra-operatively, 1gram intravenous infusion.
Study NCT03859102 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous Dexamethasone intra-operatively
Description: One dose of Dexamethasone intra-operatively as an anti-emetic, 8mg intravenous.
Study NCT03859102 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous Ondansetron intra-operatively
Description: One dose of Ondansetron intra-operatively as an anti-emetic, 4mg intravenous
Study NCT03859102 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Infiltration of surgical wounds with local anaesthetic
Description: Infiltration of surgical wounds with local anaesthetic at the end of surgery, Bupivacaine 1-2mg/kg.
Study NCT03859102 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous Magnesium intra-operatively
Description: One infusion of intravenous Magnesium Sulphate intra-operatively as an analgesic, 50mg/kg given over 30minutes.
Study NCT03859102 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Post-operative Gabapentin analgesia
Description: Post-operative oral Gabapentin 300mg, three times daily as an analgesic.
Study NCT03859102 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Post-operative oral Paracetamol analgesia
Description: Post-operative Paracetamol as an analgesic. Initially intravenously, then orally. One gram four times daily.
Study NCT03859102 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Post-operative Ondansetron anti-emesis
Description: Intravenous Ondansetron administered post-operatively as prophylactic anti-emesis. 4mg three times daily, for 24 hours. Then as required.
Study NCT03859102 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Early extubation
Description: Removal of the endotracheal tube in the Intensive Care Unit as soon as is safe.
Study NCT03859102 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Early mobilisation/physiotherapy
Description: Mobilisation (active and passive limb movements, deep breathing) with the assistance of nurse/physiotherapist to occur as soon as possible post-operatively.
Study NCT03859102 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Encourage early oral food intake
Description: Patients will be encouraged to start eating as soon as possible post-operatively
Study NCT04418310 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Lay open and curettage
Description: Lay open and curettage
Study NCT04418310 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endoscopic (E.P.Si.T) method
Description: Endoscopic (E.P.Si.T) method
Study NCT02409979 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Carbon dioxide method
Description: Insufflation with CO2 during insertion and withdrawal phases of colonoscopy.
Study NCT02409979 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Water Exchange-CO2
Description: Insertion using water exchange, withdrawal using CO2 insufflation.
Study NCT02409979 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Water Exchange-AI
Description: Insertion using water exchange, withdrawal using air insufflation.
Study NCT01034423 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: sun flower oil
Description: Capsules with sun flower oil.
Study NCT01592838 — intervention group
Intervention type: OTHER
Intervention: Data collection
Description: The participating centre will be requested to generate a coded list of all hospitalisations taken place during the study period (June 1st 2004- May 31st 2010) and analysed for changes in hospital pattern pre- versus post-rotavirus vaccination, in children aged ≤15 years.
Study NCT01414296 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PSMA ADC
Description: PSMA ADC administered IV
Study NCT03692806 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Stablor
Description: Stablor sachet
Study NCT03692806 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo sachet
Study NCT02709369 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HIRREM
Description: HIRREM is a noninvasive, closed-loop, allostatic, acoustic stimulation neuro-technology to facilitate recipient-unique relaxation, auto-calibration, and self-optimization of cortical neural oscillations by reflecting auditory tones in near real time. After an initial HIRREM assessment, evaluating patterns of brain electrical rhythms, subjects get a series of 90-120 minute HIRREM sessions, including 5 to 9 individualized protocols. A protocol is a combination of sensor montage and specific software design, during which dominant brain frequencies, recorded at high spectral resolutions, are translated to audible tones, and reflected back via earphones with as little as 8 milliseconds delay. Protocols are received sitting or reclining in a chair, some with eyes open, others eyes closed.
Study NCT04229576 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: TENs
Description: Assessing the efficacy of TENs in pain relieve during office hysteroscopy .
Study NCT04229576 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: TENs
Description: Assessing the efficacy of TENs in pain relieve during office hysteroscopy .
Study NCT02371005 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: Cone Beam Computed Tomography (CBCT)